(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione ??? ???
?? ??:
14805-29-9
???:
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione
???(??):
(3aR,4S,7R,7aS)-Hexahydro-1H-4,7-Methanoisoindole-1,3(2H)-dione;exo-2,3-NorbornanedicarboxiMide;exo-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione;hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione;(3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione;Nsc238001;lurasidone-3;Lurasidone INT 1;Lurasidone Impurity 33;Lurasidone Impurity 91
CBNumber:
CB32473726
???:
C9H11NO2
??? ??:
165.19
MOL ??:
14805-29-9.mol
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione ??
???
173-176℃
?? ?
355℃
??
1.285
???
171℃
?? ??
2-8°C
???
?????(?? ???), ???(?? ???)
??? ??
??
??? ??
??? ??
?? ?? (pKa)
11.85±0.20(Predicted)
??
???? ?? ????
InChI
InChI=1/C9H11NO2/c11-8-6-4-1-2-5(3-4)7(6)9(12)10-8/h4-7H,1-3H2,(H,10,11,12)/t4-,5+,6+,7-
InChIKey
RIVOBMOBWMOLDJ-RNGGSSJXNA-N
SMILES
C1(=O)[C@]2([H])[C@@]([H])([C@]3([H])C[C@@]2([H])CC3)C(=O)N1 |&1:2,4,6,9,r|
??
?? ? ?? ??
?? ? ???? ?? (GHS)
????(GHS):
?? ?:
Danger
??·?? ??:
??
??·?? ??
?? ??
??
?? ?
?? ??
P- ??
H315 ??? ??? ???
????? ?? ?????
?? 2
??
P264, P280, P302+P352, P321,P332+P313, P362
H317 ????? ?? ??? ??? ? ??
?? ??? ??
?? 1
??
P261, P272, P280, P302+P352,P333+P313, P321, P363, P501
H318 ?? ?? ??? ???
?? ? ?? ?? ??? ??
?? 1
??
P280, P305+P351+P338, P310
??????:
P280 ????/???/???/?????? ?????.
P305+P351+P338 ?? ??? ? ?? ?? ???? ????. ???? ?????? ?????. ?? ????.
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione C??? ??, ??, ??
??? ??
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione, white to almost white powder to crystalline in appearance, melting point 152°C, stored at 2-8°C.
??
(3AR,4S,7R,7AS) 4,7-methylene-1H-isoindole-1,3(2H)-dione can be used as an intermediate for organic synthesis and pharmaceutical research and development, suitable for laboratory organic synthesis It can be used as the raw material for the synthetic raw material medicine lurasidone in the synthesis process of chemical medicine.
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione ?? ?? ? ???
???
?? ??
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione ?? ??
???( 342)?? ??
Americas 1
China 313
Europe 1
Germany 2
India 13
Japan 1
United States 11
Global 342
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione ?? ??:
trans-1,2-Cyclohexanedicarboxylic acid
(S)-Amlodipine
s,s-endo-lurasidone HCl
3-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]-1,2-benzothiazole
Lurasidone Impurity 24
MDYJLJKDGQUHSJ-HTWOXQOSSA-N
Nsc237999
Lurasidon hydrochloride iMpurity
dihydro-o-xylene
MAVBUKOHERNHBQ-UHFFFAOYSA-N
(3aR,4S,7R,7aS)-2-{(1R,2S)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylMethyl]cyclohexylMethyl}hexahydro-4,7-Methano-2H-isoindole-1,3-dione hydrochloride
Lurasidone Impurity 2
(3aR,4S,7R,7aS)-2-[[(1S,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione
Pimecrolimus
(1R,2R)-1,2-CYCLOHEXANEDIMETHANOL
(1R,2R)-(-)-1,2-CYCLOHEXANEDICARBOXYLIC ACID
